Brief: Greenlight Biosciences Reports Q4 Net Loss Per Share of 0.26
Mar 28 (Reuters) - Greenlight Biosciences Q4 collaboration revenue USD 2.947 million. * Q4 basic EPS USD -0.26 * Q4 net income USD -38.764 million
Recent news on Greenlight Biosciences Holdings PBC
See all newsBrief: Greenlight Biosciences To Cut Workforce By About 51%
U.S. RESEARCH ROUNDUP-Microsoft, Chevron, Carisma Therapeutics
U.S. STOCKS ON THE MOVE-Netflix, Hewlett Packard Enterprise, Digital Realty
U.S. STOCKS ON THE MOVE-AI stocks, Broadcom, T2 Biosystems
GreenLight Biosciences gains on deal to be acquired by Fall Line Capital